Homeopathy in the public health system: a seven-year observational study at Lucca Hospital (Italy)

Objective: To evaluate the response to homeopathic treatment in a public homeopathic clinic of all patients attending between September 1998 until December 2005, and to analyze homeopathic practice.

Methods and setting: Longitudinal observational study in a homeopathic clinic based in a public hospital in Lucca, Italy. Data relating to patient details, clinical diagnosis, remedy prescribed, potency of dosage, prescription strategy and identification of the case as acute-chronic-recurrent were analyzed. Clinical response was assessed by the Glasgow Homeopathic Hospital Outcome Score.

Results: Overall 74% of patients reported at least moderate improvement. Outcomes were better with longer treatment duration and younger age of patients. Respiratory, followed by dermatological and gastrointestinal pathologies responded best, psychological problems relatively poorly.

Conclusions: Homeopathic therapy is associated with improvement in a range of chronic and recurring pathologies. Certain characteristics of patient and pathology influence the outcome.

Keywords

homeopathy - outcomes - chronic pathologies - public health system - Italy

• References

• 1 Menniti-Ippolito F., Gargiulo L., Bologna E., Forcella E., Raschetti R. Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol 2002; 58: 61-64.
• 2 Istituto nazionale di statistica (Istat) (National Statistics Institute). Le medicine non convenzionali in Italia. Non conventional medicine in Italy. Year of 2005 <http://www.istat.it/salastampa/comunicati/non_calendario/20070821_00/testointegrale.pdf> August 2007 [accessed in January 2009]
• 3 2005/2007 Regional Health Plan. <http://www.salute.toscana.it/parliamodi/med-non-convenzionali/realta-toscana.shtml/normativa.shtml> [accessed in January 2009]
• 4 Tuscan Regional Executive Resolution No. 655 of 20.06.2005, Tuscan Regional Integrative Agreement for Specialist Clinics. <http://www.salute.toscana.it/parliamodi/med-non-convenzionali/realta-toscana.shtml/normativa.shtml> [accessed in January 2009]
• 5 De Schepper L. LM potencies: one of the hidden treasures of the sixth edition of the Organon. Br Homeopath J 1999; 88: 128-134.
• 6 Rezzani CM. WinChip: computerized homeopathic investigation program: a data collection tool to help the doctor in daily practice and a real instrument to prove and improve homeopathy. In: Proceedings of the International Conference “Improving the Success of Homeopathy 2. Developing and Demonstrating Effectiveness” London, 15–16 April 1999; 32.
• 7 Richardson W.R. Patient benefit survey: Liverpool Regional Department of Homoeopathic Medicine. Br Homeopath J 2001; 90 (03) 158-162.
• 8 Robinson T. Responses to homeopathic treatment in National Health Service general practice. Homeopathy 2006; 95: 9-14.
• 9 Endrizzi C., Rossi E. Patient compliance with homeopathic therapy. Homeopathy 2006; 95: 206-214.
• 10 Witt C.M., Lüdtke R., Baur R., Willich S.N. Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health 2005; 5: 115 <http://www.biomedcentral.com> [accessed in February 2009]
• 11 Spence D.S., Thompson E., Barron S.J. Homeopathic treatment for chronic disease: a 6 year University Hospital outpatients observational study. J Altern Complement Med 2005: 793-798
• 12 Güthlin C., Lange O., Walach H. Measuring the effects of acupuncture and homoeopathy in general practice: an uncontrolled prospective documentation approach. BMC Public Health 2004; 4: 6 <http://www.biomedcentral.com> [accessed in February 2009]
• 13 Wassenhoven van M., Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy 2004; 93: 3-11.
• 14 Trichard M., Chaufferin G., Nicoloyannis N. Pharmaeconomic comparison between homeopathic and antibiotic treatment strategies in recurrent acute rhinopharyngitis in children. Homeopathy 2005; 94: 3-9.
• 15 Rossi E., Crudeli L., Endrizzi C., Garibaldi D. Cost–benefit evaluation of homeopathic vs conventional therapy in respiratory disease. Homeopathy 2009; 9: 2-10.
• 16 Italian Government, National Bioethics Committee. Scopi, limiti e rischi della medicina, 14 dicembre 2001 cap. 4. Objectives, limitations and risks of medicine, 14 December 2001, Chapter 4. <http://www.governo.it/bioetica/testi/141201.html> [accessed in January 2009]
• 17 Endrizzi C., Rossi E., Crudeli L., Garibaldi D. Harms in homeopathy: aggravations, adverse drug events or medication errors?. Homeopathy 2005; 94: 233-240.
• 18 Cassano P., Fava M. Depression and public health an overview. J Psychosom Res 2002; 53: 849-857.
• 19 Katz T., Fisher P., Katz A., Davidson J., Feder G. The feasibility of a randomised, placebo-controlled clinical trial of homeopathic treatment of depression in general practice. Homeopathy 2005; 94: 145-152.